Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calf blood eye drops versus 0.3% sodium hyaluronate for dry eye-related corneal neuralgia
ChiCTR1900022911Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- May 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of sodium hyaluronate in dry eye syndrome (DED) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Ocular Surface Disease Index, Tear film break-up time and 4 more. Planned start May 2019; status: not yet recruiting.
02
Drugs
sodium hyaluronate
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR1900022911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022911.